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Not All Nosocomial Escherichia coli
Bacteriurias Are Catheter Associated
Urinary tract infections (UTIs) are the most common hos-
pital-acquired infections and are thought to be primarily a
consequence of urinary catheterization.1 Strategies to prevent
hospital-acquired UTIs focus almost exclusively on urinary
catheter management. However, data to support the as-
sumption that hospital-acquired UTIs can be equated with
catheter-associated UTIs are very limited. In a recent editorial
for a nationwide survey of practices to prevent hospital-
acquired UTIs, the author stated that 80% of these infections
were catheter associated but did not provide a reference.2
We performed a 12-month prospective cohort study in-
volving inpatients with Escherichia coli bacteriuria (defined
as greater than or equal to colony-forming units/mL45# 10
in a clean-voided urine culture, or greater than or equal to
colony-forming units/mL in urine culture from a35# 10
catheterized patient) starting August 1, 2009, at Barnes-Jewish
Hospital, a 1,250-bed teaching hospital in Missouri. Adult
patients with a first positive urine culture 48 hours or more
after admission were included. Urine cultures were performed
at the treating physician’s discretion. We excluded patients
with polymicrobial bacteriuria and/or concurrent, non–E. coli
bacteremia. Using medical records, the patients’ clinical pre-
sentation, vital signs, and laboratory, radiological, and phar-
macy data were recorded prospectively.
A bacteriuria episode was considered to be catheter asso-
ciated if a catheter had been in place within 48 hours before
urine cultures were obtained. Asymptomatic bacteriuria
(ASB) was defined as the absence of urinary symptoms;3 cys-
titis was defined as the presence of dysuria, frequency, or
urinary retention; pyelonephritis was defined as flank pain
or tenderness and/or fever (with or without cystitis symp-
toms). Sepsis was defined using established criteria. We re-
viewed blood cultures that were obtained within 1 day before
or after bacteriuria was diagnosed.
We used SPSS 18 for data analysis. Univariate comparisons
of categorical variables were performed with the x2 test or
Fisher’s exact test as appropriate. Continuous independent
variables were analyzed using Student’s t test or the Mann-
Whitney U test. A 2-sided P value of less than .05 was con-
sidered significant. We entered variables with a P value of less
than 0.1 in univariate testing into a multivariate logistic re-
gression model. The study was approved by the Washington
University Human Research Protection Office.
One hundred eighty-three patients had hospital-acquired
E. coli bacteriuria during the study period and met study
criteria. Patients received a diagnosis of ASB (77 patients;
42%), cystitis (28 patients; 15%), pyelonephritis (55 patients;
30%), or unclassifiable bacteriuria (e.g., bacteriuria diagnosed
in intubated patients; 23 patients; 13%). Among asymptom-
atic patients, 65 (84%) were female.
Eighty-five of 183 episodes (46%; 95% confidence interval,
37%–56%) were catheter associated. Patients with catheter-
associated bacteriuria were more likely to be male (Pp
), to have renal insufficiency ( ), and to have un-.003 Pp .02
dergone a recent urological procedure ( ; Table 1).Pp .03
There was no difference in the prevalence of ASB ( ).Pp .6
One hundred fifty-one patients with bacteriuria (83%) re-
ceived antibiotic treatment, including 64 (83%) of the pa-
tients with ASB. The presence of a catheter did not determine
whether antibiotics matched susceptibilities (70 [99%] of 71
with catheter vs 77 [96%] of 80 without catheter; ).Pp .6
Among those patients tested for bacteremia, there was no
difference in the frequency of bacteremia ( ). In-hos-Pp .5
pital mortality was similar among those with catheter-asso-
ciated bacteriuria and those with non-catheter-associated bac-
teriuria ( ), as was the length of hospital stay afterP 1 .99
bacteriuria ( ). Independent factors predisposing toPp .08
catheter-associated bacteriuria in bacteriuric patients are
shown in Table 1.
It is widely assumed that the terms “hospital-acquired bac-
teriuria” and “catheter-associated bacteriuria” are synony-
mous. However, few data actually quantify urinary catheter-
ization as a precursor of bacteriuria. The 1983 Centers for
Disease Control and Prevention guidelines for prevention of
catheter-associated UTI state that 66%–86% of episodes of
hospital-acquired bacteriuria are secondary to urinary in-
strumentation.4 The corresponding reference does not ex-
plicitly provide this information.5 Also, to our knowledge,
this statement has not been reevaluated over the past 3 de-
cades. We found that only 46% of cases of hospital-acquired
bacteriuria in a tertiary-care hospital were catheter associated,
which is lower than was previously suspected. Why there was
such a high proportion of noncatheterized patients with bac-
teriuria is unclear. Changes in genitourinary hygiene during
hospitalization may play a role, as could medications that
alter the bladder function. It is possible that hospital policies
to reduce unnecessary device use resulted in a lower pro-
portion of catheter-associated bacteriuria. The development
of targeted preventive measures clearly depends on a better
understanding of the pathogenesis of non-catheter-associated
nosocomial bacteriuria.
In noncatheterized patients, ASB may have been present
before hospital admission but remained undetected until later
in the hospital course, leading to patients being mislabeled as
having nosocomial bacteriuria. Testing this hypothesis would
require that admission urine samples for culture be obtained
from patients. Antibiotic treatment of ASB was common (oc-
curring in 83% of cases), independent of catheter status. Al-
though ASB-related antibiotic overuse in long-term care fa-
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table 1. Comparison of Patients with Catheter-Associated and Non-Catheter-Associated Hospital-Acquired Escherichia coli Bacteriuria
Variable
Total
(n p 183)
Catheter-associated
(n p 85)
Non-catheter-associated
(n p 98) P OR (95% CI)
Male sex 46 (25) 30 (35) 16 (16) .003 2.8 (1.4–5.7)
White race 124 (68) 60 (71) 64 (65) .4 ...
Age, median years (range) 70 (20–98) 68 (24–96) 71 (20–98) .9 ...
Body mass index, median index (range) 27.1 (12.1–64.2) 27.0 (17.2–64.2) 27.3 (12.1–63.1) .7 ...
Charlson comorbidity score, median score
(range) 3 (0–13) 3 (0–13) 3 (0–11) .4 ...
Diabetes mellitus 64 (35) 31 (37) 33 (34) .7 ...
Renal insufficiency (Cr level 11.5 mg/dL) 42 (23) 26 (31) 16 (16) .02 2.2 (1.0–4.6)
Any malignancy 50 (27) 26 (31) 24 (25) .4 ...
Dementia 32 (18) 10 (12) 22 (22) .06 0.5 (0.2–1.2)
Benign prostatic hyperplasia 12 (7) 8 (9) 4 (4) .1 ...
Urological procedure during current
hospitalization 8 (4) 7 (8) 1 (1) .03 10.4 (1.2–88.8)
Fever 52 (28) 23 (27) 29 (30) .7 ...
Confusion or altered mental status 47 (26) 23 (27) 24 (25) .7 ...
Sepsis 98 (54) 47 (55) 51 (52) .7 ...
Pyelonephritis 55 (30) 25 (29) 30 (31) .9 ...
Asymptomatic bacteriuria 77 (42) 34 (40) 43 (44) .6 ...
Urinalysis results 110 WBC/hpf 121 (66) 61 (72) 60 (61) .1 ...
Outcome
Bacteremia 9/70 (13) 3/33 (9) 6/37 (16) .5 ...
Length of hospital stay after bacteriuria,
median days (range) 4.9 (0.1–66.1) 5.6 (0.2–36.5) 4.2 (0.1–66.1) .08 ...
In-hospital mortality 13 (7) 6 (7) 7 (7) 1.99 ...
note. Data are no. (%) of patients unless otherwise specified. Hosmer-Lemeshow goodness-of-fit (for the multivariate logisticPp .635
regression model). Body mass index was calculated as the weight in kilograms divided by the square of height in meters. CI, confidence
interval; Cr, creatinine; hpf, high-power field; OR, odds ratio; WBC, white blood cell.
cilities has stimulated interventions,6 comparable data for
acute-care hospitals are lacking. ASB may be a major driver of
antibiotic use (and antimicrobial resistance) in hospitals and
therefore represents a target for antimicrobial stewardship.7
We identified a number of plausible independent predictors
of catheter-associated bacteriuria. The lower prevalence of
catheter-associated bacteriuria among bacteriuric women
could be in line with their predisposition to ASB.8 The need
for monitoring fluid intake and output may contribute to a
higher frequency of catheterization among bacteriuric pa-
tients with renal insufficiency. Finally, catheters have been
shown to result in postprocedure UTIs.9
Our data were obtained from medical records, including
both physicians’ and nurses’ notes. It is possible that some
urinary catheterizations were unrecorded, which may have
led us to underestimate the number of catheter-associated
bacteriurias. The imperfect correlation between catheteriza-
tion and its documentation has been addressed in a recent
study.10 Also, the proportion of catheter-associated episodes
might be higher for nosocomial pathogens other than E. coli.
In summary, we found catheter-associated infection to be
less common among cases of nosocomial E. coli bacteriuria
than has been previously reported. A better understanding
of non-catheter-associated bacteriuria could lead to improved
infection-prevention strategies among hospitalized patients.
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